← All Signals

🏥 FDA: HTO Nevada Inc. dba Kirkman — Class II

healthcareneutralSource: FDA
70%Confidence
0Views
FDASource
2026-03-20Date

Summary

Kirkman's Vasocaine Spray recall due to unsupported expiry dates indicates potential stability and efficacy concerns for this topical anesthetic. This could impact dental and medical procedures relying on this product and damage the brand's reputation.

Actionable: Verify expiry dates and storage conditions for all Kirkman topical anesthetic products in inventory.

AI Confidence: 70%

Data Points

firmHTO Nevada Inc. dba Kirkman
classificationClass II
statusOngoing
distributionNationwide within the U.S
productFIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-01

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now